Published November 2015 | Version v1
Journal article

The advantage and risk of 131I treatment in hyperthyroidism combined with liver injury or blood cell reduction

  • 1. Department of Nuclear Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou (China)

Description

At present, anti-thyroid drugs, radioactive iodine(131I) and surgical therapy were considered as the three major methods for hyperthyroidism therapy. With the acceptance of the safety of 131I therapy in hyperthyroidism, more and more patients become to choose it as their therapeutic method, especially the patients with liver injury or blood cell reduction complications. This paper summaries the advantages and risks of 131I therapy in this two special hyperthyroidism patients groups according to the recent paper and clinical practice. (authors)

Additional details

Publishing Information

Journal Title
International Journal of Radiation Medicine and Nuclear Medicine
Journal Volume
39
Journal Issue
6
Journal Page Range
p. 483-486, 492
ISSN
1673-4114

Optional Information

Notes
37 refs.; http://dx.doi.org/10.3760/cma.j.issn.1673-4114.2015.06.010